Vitamin D status in patients with chronic plaque psoriasis

British Journal of Dermatology

Volumn 166, Issue 3, 2012, Pages 505-510

  Gisondi, P ^a   Rossini, M ^b   Di Cesare, A ^c   Idolazzi, L ^b   Farina, S ^a   Beltrami, G ^b   Peris, K ^c   Girolomoni, G ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; VITAMIN D DEFICIENCY; WINTER;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CALCIUM; CASE-CONTROL STUDIES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PSORIASIS; SEASONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84857511315     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10699.x     Document Type: Article

References (38)

1. Rosen CJ,. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011; 364: 248-54.
2. Van der Wielen RP, Löwik MR, Van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995; 346: 207-10.
3. Thacher TD, Clarke BL,. Vitamin D insufficiency. Mayo Clin Proc 2011; 86: 50-60.
4. Adami S, Viapiana O, Gatti D, et al. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 2008; 42: 267-70.
5. Institute of Medicine. IOM Report on Calcium and Vitamin D. Washington, DC: Institute of Medicine, 2010. Available at: (last accessed 24 November 2011).
6. LoPiccolo MC, Lim HW,. Vitamin D in health and disease. Photodermatol Photoimmunol Photomed 2010; 26: 224-9.
7. Gniadecki R, Gajkowska B, Hansen M,. 1, 25-dihydroxyvitamin D3 Stimulates the assembly of adherens junctions in keratinocytes: involvement of protein kinase C. Endocrinology 1997; 138: 2241-8. (Pubitemid 27215221)
8. Zold E, Barta Z, Bodolay E,. Vitamin D deficiency and connective tissue disease. Vitam Horm 2011; 86: 261-86.
9. Lonergan R, Kinsella K, Fitzpatrick P, et al. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 2011; 82: 317-22.
10. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69: 1155-7.
11. Alamanos Y, Voulgari PV, Drosos AA,. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006; 36: 182-8. (Pubitemid 44691887)
12. Farraye FA, Nimitphong H, Stucchi A, et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis 2011; 17: 2116-21.
13. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73. (Pubitemid 44205029)
14. Glanz K, Yaroch AL, Dancel M, et al. Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Arch Dermatol 2008; 144: 217-22. (Pubitemid 351287004)
15. Rossini M, Maddali Bongi S, La Montagna G, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010; 12: R216.
16. Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf) 2010; 73: 277-85.
17. Dreiher J, Weitzman D, Cohen AD,. Psoriasis and osteoporosis: a sex-specific association? J Invest Dermatol 2009; 129: 1643-9.
18. Devaraj S, Jialal G, Cook T, et al. Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm Metab Res 2011; 43: 72-4.
19. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-9. (Pubitemid 351930842)
20. Gottlieb AB, Dann F,. Comorbidities in patients with psoriasis. Am J Med 2009; 122: 1150. e1- 9.
21. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73. (Pubitemid 46934281)
22. Abuabara K, Azfar RS, Shin DB, et al. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010; 163: 586-92.
23. Schwalfenberg GK,. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011; 55: 96-108.
24. Van de Kerkhof PC,. An update on vitamin D3 analogues in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 1998; 11: 2-10. (Pubitemid 28266285)
25. Tang L, Yu Y, Chen J, et al. The inhibitory effect of VitD3 on proliferation of keratinocyte cell line HACAT is mediated by down-regulation of CXCR2 expression. Clin Exp Dermatol 2003; 28: 416-19. (Pubitemid 36801848)
26. Lehmann B,. Role of the vitamin D3 pathway in healthy and diseased skin-facts, contradictions and hypotheses. Exp Dermatol 2009; 18: 97-108.
27. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009; 60: 643-59.
28. Ryan C, Moran B, McKenna MJ, et al. The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland. Arch Dermatol 2010; 146: 836-42.
29. Perez A, Raab R, Chen TC, et al. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol 1996; 134: 1070-8. (Pubitemid 26183140)
30. Thivolet J, Martin-Bourret V,. Treatment of psoriasis by oral calcitriol. Ann Dermatol Venereol 1994; 121: 252.
31. Werner de Castro GR, Neves FS, Pereira IA, et al. Resolution of adalimumab-induced psoriasis after vitamin D deficiency treatment. Rheumatol Int 2011; Feb 3 [Epub ahead of print].
32. DeLuca HF,. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80 (Suppl.): 1689S-96S.
33. Peroni DG, Piacentini GL, Cametti E, et al. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 2011; 164: 1078-82.
34. Thorp WA, Goldner W, Meza J, Poole JA,. Reduced vitamin D levels in adult subjects with chronic urticaria. J Allergy Clin Immunol 2010; 126: 413.
35. Silverberg JI, Silverberg AI, Malka E, Silverberg NB,. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol 2010; 62: 937-41.
36. Kriegel MA, Manson JE, Costenbader KH,. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 2011; 40: 512-31.
37. van den Bergh JP, Bours SP, van Geel TA, Geusens PP,. Optimal use of vitamin D when treating osteoporosis. Curr Osteoporos Rep 2011; 9: 36-42.
38. Shroff R, Knott C, Rees L,. The virtues of vitamin D-but how much is too much? Pediatr Nephrol 2010; 25: 1607-20.